Focus on

Focus Farmacovigilanza 2017;97(6):1
The skin is frequently affected by adverse drug reactions and basically any class of drugs – but NSAIDs, antibiotics and antiepileptic drugs (AEDs) with particular frequency – can cause them (see table).1Children with an adverse drug reaction present a cutaneous manifestation in 16% to 35% of cases...
Focus Farmacovigilanza 2017;96(3):1
The management of the pharmacological therapy in the elderly patient has become more and more a relevant and critical aspect.1 The physiological aging process is characterised by structural and functional changes that affect all systems and translate in a reduced ability to maintain homeostasis and...
Focus Farmacovigilanza 2016;95(11):5
Acetaminophen is generally considered safe during pregnancy. However, recent studies seem to link its use with some risks for the unborn. The signal has been highlighted by researchers of the University of Bristol and Cardiff, whom analyzed the long-term results of a cohort enrolled at birth (7,796...
Focus Farmacovigilanza 2016;94(9):1
These products are generally considered completely harmless, but their active ingredients exert a biological function in the organism and can, therefore, have side effects or interact with drugs. Non-conventional medicines in Italy Non-conventional therapies are therapeutic practices,...
Focus Farmacovigilanza 2016;93(3):7
Chronic renal failure represents nowadays one of the biggest public health issues worldwide: it is estimated that in Italy one person over seven people has a moderate impairment of the renal function, i.e. a halved renal functionality, or more than halved, in comparison with the norm.1 Chronic...
The International School of Pharmacology of the Ettore Majorana Foundation and Centre for Scientific Culture (EMFCSC) in Erice, Sicily organizes a Course on "Medication Errors" from 2nd to 6th May 2016. A medication error is an unintended failure in the treatment process that leads to, or has the...
Nello Martini, ex director and founder of the Italian Agency of Medicines (AIFA, in Italian) previously committed for trial by the state’s attorney of Turin Guariniello with the charge of “involuntary disaster” (literal translation of an Italian legal term) for the delayed update of 20 drug...
Focus Farmacovigilanza 2015;90(9):4
Our website www.farmacovigilanza.eu (and its English version www.pharmaco-vigilance.eu) continues to grow. The number of users has doubled in the last year. With only two months left from the end of 2015 we can estimate that in December we will have reached and passed 200,000 yearly visitors. This...
Focus Farmacovigilanza 2015;90(9):3
Multiple sclerosis (MS) is a demyelinating disease of the central nervous system that usually affects young people with a peak in incidence between 20 and 40 years of age and whose manifestations are focal and diffuse damage from its onset; symptoms vary according to the affected area of the...
Focus Farmacovigilanza 2015;89(8):3
In Europe, according to the European Monitoring Centre (EMCDDA, 2013)1, 22% (70 million) of those aged between 15 and 64 years have used cannabis preparations (mainly marijuana) for recreational purposes at least once in their lifetime, 7% (23 million) within the last year, and 4% (14 million)...

Pages